This page is dedicated to the Genodermatoses research study, one of over 60 studies supported by the Boston Children’s Rare Disease Collaborative (CRDC). For more information about the CRDC, please visit our home page. Established in 2018, the CRDC supports pediatric rare disease research and provides families with genetic diagnoses that enable personalized treatments, including precision medicine and targeted therapies.
Section Chief, Dermatology; Director, Pediatric Oncodermatology; Program Director, Harvard Combined Dermatology Residency Training
Associate Professor of Dermatology and Pediatrics, Harvard Medical School
The Genodermatoses research study was established in 2025 and is led by Drs. Zinan Zhang and Jennifer Huang.